# Ulcerative Colitis:  Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/ulcerative-colitis-developing-drugs-for-treatment/9c536649-649f-4c1e-b31a-8ed733f15831

> FDA guidance document: Ulcerative Colitis:  Developing Drugs for Treatment. Issue date: April 28, 2022. Get complete insights and analysis.

---

## Details

- Title: Ulcerative Colitis:  Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-04-28
- Comment Close Date: 2022-06-28
- Last Changed: 2022-10-31
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-0140">FDA-2022-D-0140</a>

## Related Documents

- [Erosive Esophagitis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment/985e94e3-4616-49e9-822e-0854256bb10e)
- [Disseminated Coccidioidomycosis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/disseminated-coccidioidomycosis-developing-drugs-for-treatment/57566736-a0f1-4c1b-b09c-f05bfb8ce885)
- [Crohn’s Disease:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/crohns-disease-developing-drugs-for-treatment/10ab5c94-72ed-489d-b2cc-24cf6914fed5)